CR-27303

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCR-27303
Drug Alias NameCR-27303
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmbryx Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbryx Biotechnology
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A